Jones Hill Capital »

Syndax Pharmaceuticals shares owned by Jones Hill Capital

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Jones Hill Capital from 13F filings

Historical chart of Jones Hill Capital investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Jones Hill Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Jones Hill Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.4M 340k 21.86

More positions owned by Jones Hill Capital

BioMarin Pharmaceutical (BMRN)
Gilead Sciences (GILD)
Arcutis Biotherapeutics (ARQT)
Madrigal Pharmaceuticals (MDGL)
Bicara Therapeutics (BCAX)
Relmada Therapeutics (RLMD)
Trevi Therapeutics (TRVI)
Pharvaris N V (PHVS)
Xenon Pharmaceuticals (XENE)
Biosante Pharmaceuticals (ANIP)
Immunocore Hldgs Ads (IMCR)
Amylyx Pharmaceuticals (AMLX)
Insmed Com Par $.01 (INSM)
Nuvalent Inc-a (NUVL)
Capricor Therapeutics Com New (CAPR)

View all positions for Jones Hill Capital

Top funds holding Syndax Pharmaceuticals

BlackRock
Kynam Capital Management
Goldman Sachs Group
State Street Corporation
Bank of America Corporation
Vanguard Capital Management
Deerfield Management Company
Eversept Partners
Geode Capital Management
Hood River Capital Management
Kingdon Capital Management
Franklin Resources
Millennium Management
Vanguard Portfolio Management
UBS Group

View all funds holding Syndax Pharmaceuticals